Cineverse Reports Q2 Revenue of $12.4 Million with 58% Operating Margin

Reuters
11/15
<a href="https://laohu8.com/S/CNVS">Cineverse</a> Reports <a href="https://laohu8.com/S/QTWO">Q2</a> Revenue of $12.4 Million with 58% Operating Margin

Cineverse Corp. announced its financial results for the second quarter of fiscal year 2026, reporting total revenue of $12.4 million. The company's total revenue declined 3% year-over-year, mainly due to timing differences in revenue recognition for certain content licensing agreements. In the prior-year quarter, $1.6 million was recorded from a Dog Whisperer licensing agreement, while the current quarter includes a $1.1 million licensing deal for The Toxic Avenger Unrated, which will be recognized in future periods. The direct operating margin increased to 58%, a 7 percentage point improvement over the prior-year quarter. Adjusted EBITDA and net income were impacted by planned investments in Cineverse's wide-release film business and Technology group. The company also noted ongoing cost efficiencies from its Cineverse Services India operations. Cineverse highlighted continued growth in its Matchpoint™ platform, which added over 20 new customers in the last 100 days and entered a pilot program with a major Hollywood studio.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cineverse Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA25312) on November 14, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10